BFRF1 of Epstein-Barr virus is essential for efficient primary viral envelopment and egress.
The molecular mechanisms that underlie maturation and egress of Epstein-Barr virus (EBV) virions are only partially characterized. We have recently shown that the BFRF1 gene, the EBV positional homolog of herpes simplex virus type 1 and pseudorabies virus UL34, is expressed early during EBV lytic replication and that it is found predominantly on the nuclear membrane (A. Farina, R. Santarelli, R. Gonnella, R. Bei, R. Muraro, G. Cardinali, S. Uccini, G. Ragona, L. Frati, A. Faggioni, and A. Angeloni, J. Virol. 74:3235-3244, 2000). These data suggest that the BFRF1 protein might be involved in viral primary envelopment. To precisely determine the function of this protein, we have constructed an EBV mutant devoid of the BFRF1 gene (BFRF1-KO). 293 cells carrying BFRF1-KO showed no differences in comparison with wild-type EBV in terms of DNA lytic replication or expression of late viral proteins upon induction of the lytic cycle. However, binding assays and infection experiments using cell lines or human cord blood lymphocytes showed a clear reduction in the viral mutant titers. Complementation experiments with BFRF1-KO and a BFRF1 expression vector restored viral titers to levels similar to those for the wild-type control, showing that the modifications that we introduced were limited to the BFRF1 gene. Electron microscopic observations showed that the reduction in viral titers was due to sequestration of EBV nucleocapsids in the nuclei of lytically induced cells. This suggests that BFRF1 is involved in transport of the maturing virion across the nuclear membrane. This hypothesis was further supported by the observation that BFRF1 is present in maturing intracellular virions but not in their extracellular counterparts. This implies that BFRF1 is a key protein for EBV maturation.
Farina
Antonella
A
Istituto Pasteur Fondazione Cenci-Bolognetti, Dipartimento di Medicina Sperimentale e Patologia, Università di Roma La Sapienza, Rome, Italy.
Feederle
Regina
R
Raffa
Salvatore
S
Gonnella
Roberta
R
Santarelli
Roberta
R
Frati
Luigi
L
Angeloni
Antonio
A
Torrisi
Maria Rosaria
MR
Faggioni
Alberto
A
Delecluse
Henri-Jacques
HJ
D002460:Cell Line; D002467:Cell Nucleus / Q000648:ultrastructure / Q000821:virology; D002478:Cells, Cultured; D004261:DNA Replication; D017353:Gene Deletion; D015967:Gene Expression Regulation, Viral; D005814:Genes, Viral; D005816:Genetic Complementation Test; D004854:Herpesvirus 4, Human / Q000502:physiology*; D006801:Humans; D008214:Lymphocytes / Q000821:virology; D008565:Membrane Proteins / Q000235:genetics / Q000502:physiology*; D008854:Microscopy, Electron; D009685:Nuclear Envelope / Q000821:virology; D014764:Viral Proteins / Q000235:genetics / Q000502:physiology*; D014771:Virion / Q000378:metabolism; D019065:Virus Assembly; D014779:Virus Replication
C406064:BFRF1 protein, Human herpesvirus 4; D008565:Membrane Proteins; D014764:Viral Proteins
J Virol. 1985 Dec;56(3):860-6
2999442
J Virol. 1984 Apr;50(1):248-54
6321792
Cell. 1987 Jul 17;50(2):203-13
3036369
Virology. 1987 Sep;160(1):151-61
2820125
J Cell Biol. 1988 Mar;106(3):761-71
2450098
J Virol. 1989 Feb;63(2):828-32
2536106
J Virol. 1989 Sep;63(9):3878-83
2548003
Int J Cancer. 1990 Mar 15;45(3):490-3
2155183
J Virol. 1990 Apr;64(4):1507-16
2157039
J Virol. 1990 Jun;64(6):2545-52
2159529
J Virol. 1991 May;65(5):2728-31
1850046
Gene. 1995 May 26;158(1):9-14
7789817
J Virol. 1995 Nov;69(11):7309-14
7474160
J Virol. 1997 Mar;71(3):2072-82
9032339
J Virol. 1997 May;71(5):4092-7
9094688
J Gen Virol. 1997 Dec;78 ( Pt 12):3361-70
9400989
J Infect Dis. 1998 May;177(5):1194-201
9593003
Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8245-50
9653172
Lancet. 1964 Feb 1;1(7327):238-40
14086209
J Virol. 2005 Mar;79(6):3713-27
15731265
J Virol. 1999 Dec;73(12):9858-66
10559298
J Virol. 2000 Jan;74(1):117-29
10590098
J Virol. 2000 Feb;74(3):1355-63
10627546
J Virol. 2000 Apr;74(7):3235-44
10708440
EMBO J. 2000 Jun 15;19(12):3080-9
10856251
J Gen Virol. 2000 Oct;81(Pt 10):2397-405
10993927
J Virol. 2000 Nov;74(21):10063-73
11024135
J Virol. 2000 Nov;74(21):10142-52
11024143
J Virol. 2000 Dec;74(23):11162-72
11070013
J Natl Cancer Inst. 2001 Apr 4;93(7):560-1
11287458
J Gen Virol. 2001 Jun;82(Pt 6):1423-8
11369887
J Virol. 2001 Sep;75(18):8803-17
11507225
J Virol. 2001 Sep;75(18):8818-30
11507226
J Virol. 2002 Jan;76(1):364-78
11739701
J Virol. 2002 Feb;76(4):1537-47
11799148
Science. 2002 Aug 2;297(5582):778-9
12161637
Science. 2002 Aug 2;297(5582):854-7
12161659
J Virol. 2002 Sep;76(17):8939-52
12163613
Virology. 2002 Sep 1;300(2):189-204
12350350
Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):15036-41
12409611
J Med Virol. 2004 Jan;72(1):102-11
14635017
Blood. 2004 Jan 1;103(1):313-6
12969959
Virology. 2004 Mar 1;320(1):99-106
15003866
J Virol. 2004 Jun;78(11):5591-600
15140956
Int J Cancer. 1977 Jan;19(1):27-33
188769
J Gen Virol. 1977 Jul;36(1):59-74
886304
Nature. 1978 Mar 23;272(5651):373-5
204874
Virology. 1979 Apr 15;94(1):228-31
220786
Virology. 1979 Nov;99(1):183-7
227161
J Virol. 1981 Oct;40(1):11-9
6270367
J Mol Biol. 1983 Jun 5;166(4):557-80
6345791
Int J Cancer. 1984 Jan 15;33(1):27-32
6319296
Science. 1986 Jun 20;232(4757):1554-6
3012779